🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The primary purpose of this study is to assess the safety and tolerability ...
Status
Completed
Location
Collaborative Neuroscience Research, LLC ( Site 0004)
Start Date
2022-07-12
Trial ID
NCT05406440
Treatments Being Tested
This will be a randomized, placebo-controlled, parallel-group, multi-site, ...
Status
Completed
Location
Woodland International Research Group, LLC ( Site 0001)
Start Date
2017-03-08
Trial ID
NCT03055338
Treatments Being Tested
The purpose of this study is to evaluate the safety, tolerability, and phar...
Status
Completed
Location
California Clinical Trials Medical Group managed by PAREXEL ( Site 0003)
Start Date
2023-09-15
Trial ID
NCT05953740
Treatments Being Tested
The purpose of this study was to evaluate the efficacy and safety of elpipo...
Status
Completed
Location
Pillar Clinical Research ( Site 1047)
Start Date
2020-12-15
Trial ID
NCT04624243
Treatments Being Tested
The purpose of this study is to evaluate the safety and tolerability of mul...
Status
Completed
Location
CITrials ( Site 0007)
Start Date
2022-07-01
Trial ID
NCT05227118
Treatments Being Tested
This 3-part dose titration study will assess elpipodect safety, tolerabilit...
Status
Completed
Location
Multiple Locations
Start Date
2014-08-05
Trial ID
NCT02181803
Treatments Being Tested
The primary purpose of this study to evaluate the effect of a supratherapeu...
Status
Completed
Location
California Clinical Trials Medical Group managed by PAREXEL-PAREXEL International ( Site 0003)
Start Date
2023-06-26
Trial ID
NCT05893862
Treatments Being Tested
The purpose of this study is to learn what happens to elpipodect in a healt...
Status
Completed
Location
Labcorp Clinical Research Unit Inc. (Site 0001)
Start Date
2022-05-13
Trial ID
NCT06626464
Treatments Being Tested
This is a randomized, double-blind, 2-part clinical study of the safety, to...
Status
Completed
Location
Woodland Research Northwest, LLC ( Site 0002)
Start Date
2020-08-28
Trial ID
NCT04506905
Treatments Being Tested
This 4-panel study will evaluate the safety, tolerability, pharmacokinetics...
Status
Completed
Location
California Clinical Trials ( Site 0001)
Start Date
2018-06-20
Trial ID
NCT03565068
Treatments Being Tested